Chinese researchers promote biomedical regulations: what are the motives of the biopolitical dawn in China and where are they heading?
In the past five years, China has experienced increased efforts to regulate activities in biomedical research and practice. Background is provided on some of the key developments in Chinese bioethics especially in relation to genetics, stem cells, cloning, and reproductive medicine. This background sets the stage for a document entitled "Ethical Guidelines for Human Embryonic Stem Cell Research," proposed by the Bioethics Committee of the Southern China National Human Gene Research Center, Shanghai, which is reprinted in this volume of the Kennedy Institute of Ethics Journal.
Doring
Ole
O
China's History and Philosopy Program, Faculty for East Asian Studies, Ruhr-University Bochum, Germany.
D026688:Bioethical Issues; D035843:Biomedical Research; D002681:China; D019976:Cloning, Organism; D003132:Commerce; D003906:Developing Countries; D033041:Embryo Research / Q000331:legislation & jurisprudence; D036281:Genetic Research; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007258:Informed Consent; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D011057:Politics; D011640:Public Policy; D027724:Reproductive Techniques, Assisted / Q000331:legislation & jurisprudence; D015871:Scientific Misconduct; D013234:Stem Cells; D014019:Tissue Donors